{"schema_version":"1","generated_at":"2026-11-09T16:05:49.650Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ryan-lynch","json_url":"https://www.findmykol.com/kol/ryan-lynch/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ryan-lynch","name":"Ryan Lynch","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1386965952"},"summary":"Ryan Lynch is an Oncology physician. ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06745076","title":"Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT06745076","trial_url":"https://www.findmykol.com/trial/NCT06745076"},{"nct":"NCT05169658","title":"Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT05169658","trial_url":"https://www.findmykol.com/trial/NCT05169658"},{"nct":"NCT04231877","title":"Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT04231877","trial_url":"https://www.findmykol.com/trial/NCT04231877"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":54,"shown":3,"withheld":51,"rows":[{"payer":"Genentech","program_year":2025,"amount_usd":858406,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386965952"},{"payer":"Janssen","program_year":2025,"amount_usd":87626.54,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386965952"},{"payer":"Incyte","program_year":2025,"amount_usd":52275.57,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386965952"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1386965952","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":44.4,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":44.4,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":34.9,"classes_total":2,"classes":[{"class":"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor","setting":"prescribed","share_pct":17.5,"drugs":[{"name":"Entecavir","share_pct":100}],"max_beneficiaries":null},{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":17.5,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":20.6,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":20.6,"drugs":[{"name":"Brukinsa","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":94.9,"facility_pct":5.1},"source":"medicare"},"contact":{"address_1":"825 EASTLAKE AVE E","city":"Seattle","state":"WA","zip":"981094405","phone":"206-288-7222","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1386965952","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":51}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-07-21","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}